Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
SEC Filing Details Document Details Form 8-K Filing Date Jan 4, 2024 Document Date Dec 31, 2023 Form Description Report of unscheduled material events or corporate event Filing Group Current Reports Company Arbutus Biopharma Corporation Issuer ARBUTUS BIOPHARMA CORP Filing Formats View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML - XBRL INSTANCE DOCUMENT Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
SEC Filing Details Document Details Form 8-K Filing Date Jan 4, 2024 Document Date Dec 31, 2023 Form Description Report of unscheduled material events or corporate event Filing Group Current Reports Company Arbutus Biopharma Corporation Issuer ARBUTUS BIOPHARMA CORP Filing Formats View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML - XBRL INSTANCE DOCUMENT Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library